Online Consulting: “Nutrition and Weight Loss”

To help customers learn more about methods for losing weight safely and effectively, STADA-Vietnam Joint Venture Co., Ltd. and Thanh Nien Online held together a successful online consulting of “Nutrition and Weight Loss” on April 07, 2011.

image001

With over 400 questions sent from customers, Dr. Dao Thi Yen Phi – Head of Department of Nutrition from University of Medicine and Pharmacy Pham Ngoc Thach, and Pharmacist Nguyen Van Nhan from STADA-VN have given the safe weight-loss diet as well as how to choose the best diet pill.

 

About STELLA

STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com

You May like

13 Dec 2024

VIETNAM AIMS TO PRODUCE INNOVATIVE MEDICINES

The Ministry of Health has proposed a policy to encourage the transfer of new and innovative drugs, aiming to create more opportunities for patients. According to the ministry’s Drug Administration of Vietnam (DAV), innovative drugs in Vietnam account for only about 3% of the total but represent up to 22% of the value and are

27 Nov 2024

VIỆT NAM SEEKS TO SPEED UP NEW DRUG ACCESS

A draft version of the revised Pharmacy Law will be presented to the ongoing National Assembly session to enhance public access to new medicines. Only 9% of new medicines have been introduced in Việt Nam over the past decade, far lower than that in other Asia-Pacific countries (20%). The Head of Legal and Integration Department